WV-MT2 SEC Review: Wisdom Ventures Is Easy to Verify, but the $2.15 Million Asset Behind "MT2" Is Not
A FULLY SUBSCRIBED SPV WITH FIVE LARGE INVESTORS — BUT EDGAR DOES NOT SAY WHAT THEY BOUGHT
WV-MT2 a Series of CGF2021 LLC filed its initial Form D on October 5, 2026 and reported the entire $2.15 million offering sold to five investors only three days after its October 2 first sale. The vehicle relies on Rule 506(b) and Section 3(c)(1), reports no non-accredited investors, no sales commissions, no finder's fees and $0 of proceeds allocated to related persons in Item 16. Wisdom Ventures Fund, LLC is named directly as an executive officer and Zoë Rogers signed the filing as manager, creating a credible connection to the established Wisdom Ventures organization rather than leaving WV-MT2 as an anonymous CGF2021 Series. The problem begins with the acronym itself. The Form D provides no explanation of what "MT2" represents, does not identify an underlying startup or fund, and gives no security class, transaction valuation, share price, ownership percentage, financing round or expected holding period. Five investors supplied an average of roughly $430,000 each if subscriptions were equal, making the absence of public asset identification particularly notable. FilingDossier could not independently match MT2 to a specific Wisdom Ventures portfolio company strongly enough to publish that relationship as fact. This means the public evidence verifies the wrapper, sponsor connection and money raised, but does not verify the central investment. Investors who received private deal materials may know exactly what MT2 means; anyone relying on the SEC record does not. That is a meaningful distinction because the economic result of this Series may depend almost entirely on one private security whose identity, entry price and contractual rights remain outside EDGAR.
WISDOM VENTURES HAS A REAL TRACK RECORD, BUT SOME OF ITS MOST IMPRESSIVE PERFORMANCE LANGUAGE IS STILL MANAGER-SUPPLIED
Wisdom Ventures has substantially more sponsor history than most coded SPVs. Its first institutional Form D appeared in 2022, and the 2023 amendment for Wisdom Ventures Fund I reported $7.761 million sold to 40 investors out of a $10 million offering. The same filing explicitly says Wisdom Ventures Fund, LLC served as investment manager and warns that the GP and related persons may receive management fees based on assets and/or performance-based compensation based on profits. Wisdom's current website now says Fund I ultimately deployed $10 million across 38 companies, including OpenAI, Anthropic, Substack and Function Health, and describes the 2022-vintage fund as "top quartile" with 14 markups. Those portfolio names provide a credible explanation for why investors may be interested in new Wisdom vehicles, but the performance claim deserves careful interpretation. A markup is not the same as a cash realization, and a private-company financing at a higher valuation can increase reported NAV without producing distributable proceeds. The public website does not provide the methodology behind the "top quartile" statement, the comparison universe, DPI, TVPI, IRR, loss ratio or an independently audited schedule of realized returns. Investors in WV-MT2 therefore should not assume that owning a Series sponsored by the same firm automatically reproduces the economics of early OpenAI or Anthropic exposure. They should request actual Fund I audited financials and performance attribution, determine how much of the reported value is realized versus unrealized, and separate the historical performance of the diversified Fund I portfolio from whatever single asset or narrow exposure sits inside MT2.
EVEN THE FUND II STORY SHOWS WHY MARKETING NUMBERS AND SEC FILING NUMBERS NEED TO BE RECONCILED
Wisdom Ventures announced on May 7, 2026 that it had closed an oversubscribed $77.7 million Fund II, significantly above its original $50 million target, and says the fund is writing $1 million to $5 million checks into early-stage companies using AI to advance health, wellness and human connection. Yet the latest Fund II Form D located in this review, filed March 30, 2026, reported only $6.7 million sold to 48 investors and an indefinite offering. This should not be presented as a contradiction or evidence of misstatement: Form D data are point-in-time filings, Fund II could have closed substantial additional commitments after March 30, and private-fund SEC notices do not function as real-time fundraising dashboards. But it illustrates why investors should not mix figures from different dates or assume every marketing number is immediately reflected in EDGAR. The same caution applies to WV-MT2. Its $2.15 million amount is unusually clear because the Form D reports the entire fixed offering sold, but nothing in the filing explains whether this Series is part of Fund II's portfolio, a separate opportunity offered to selected LPs, a follow-on allocation, a secondary purchase or an investment excluded from the main fund. That distinction matters for conflicts and deal allocation. If Wisdom Ventures Fund II was already a $77.7 million fund writing $1 million–$5 million checks, investors should ask why a particular investment was placed into a separate $2.15 million Series rather than entirely inside Fund II, whether Fund II also owns the same company, how the opportunity was divided, whether both vehicles paid the same price and whether any investor group received preferential access. None of those questions implies wrongdoing, but they are classic allocation-conflict questions whenever a manager operates both a flagship fund and deal-specific SPVs.
FINAL RISK ASSESSMENT — THE SPONSOR IS MUCH STRONGER THAN THE DISCLOSURE AROUND THIS PARTICULAR DEAL
WV-MT2 therefore presents almost the reverse profile of an unknown first-time sponsor. Wisdom Ventures has an established Form D history, an active investment manager, recognizable partners, two flagship funds and a portfolio containing well-known technology and healthcare companies; state business records also show Wisdom Ventures Fund, LLC as an active investment-advice business. The new Series is fully subscribed, no sales commissions or finder's fees are reported, and no enforcement action naming WV-MT2 was identified in the records reviewed. The negative conclusion is narrower but substantial: the stronger the Wisdom Ventures brand becomes, the easier it is for investors to assume they understand an SPV whose actual asset is not publicly identified at all. MT2 remains an unexplained internal code; no matching detailed WV-MT2 private-fund disclosure was identified in the latest imported ADV data; the Series uses the standardized CGF2021 Claymont address rather than Wisdom's Los Gatos operating address; and the public record does not disclose entry valuation, security terms, fees, carry, administrator responsibilities, custody, valuation process or why this opportunity was separated from Wisdom Ventures Fund II. Investors should obtain the exact legal name of the MT2 portfolio company or fund, underlying purchase agreement, capitalization and financing-round documents, full SPV fee/carry waterfall, allocation policy between Fund II and side vehicles, confirmation that the Series purchased at the same price as other investors, and audited evidence supporting any performance claims used in marketing the manager. Our conclusion is therefore strong sponsor verification and completed fundraising, but unusually weak deal-level transparency and a genuine need to distinguish manager reputation from the economics of the specific asset held by WV-MT2.